首页> 外国专利> TREATMENT OF CANCER CELLS OVEREXPRESSING SOMATOSTATIN RECEPTORS USING OCREOTIDE DERIVATIVES CHELATED TO RADIOISOTOPES

TREATMENT OF CANCER CELLS OVEREXPRESSING SOMATOSTATIN RECEPTORS USING OCREOTIDE DERIVATIVES CHELATED TO RADIOISOTOPES

机译:使用放射性同位素螯合的奥曲肽衍生物治疗过表达生长抑素受体的癌细胞

摘要

A cancer targeting composition, kit, and method for treatment of cancer cells overexpressing somatostatin receptors is disclosed. The composition includes a radioisotope, a chelator, and a targeting moiety. The chelator includes a nitrogen ring structure including a tetraazacyclododecane, a triazacyclononane, and/or a tetraazabicyclo [6.6.2] hexadecane derivative. The targeting moiety includes a somatostatin receptor targeting peptide. The somatostatin receptor targeting peptide includes an octreotide derivative. The targeting moiety is chelated to the radioisotope by the chelator whereby the cancer cells are targeted for elimination.
机译:公开了用于治疗过表达生长抑素受体的癌细胞的癌症靶向组合物,试剂盒和方法。该组合物包括放射性同位素,螯合剂和靶向部分。螯合剂包括氮环结构,该氮环结构包括四氮杂十二烷,三氮杂壬烷和/或四氮杂双环[6.6.2]十六烷衍生物。靶向部分包括生长抑素受体靶向肽。生长抑素受体靶向肽包括奥曲肽衍生物。所述靶向部分被所述螯合剂螯合至放射性同位素,由此将癌细胞靶向消除。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号